(VIANEWS) – ABC ARBITRAGE (ABCA.PA), ORKLA (ORK.OL), OENEO (SBT.PA) are the highest payout ratio stocks on this list.
We have collected information concerning stocks with the highest payout ratio at the moment. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. ABC ARBITRAGE (ABCA.PA)
128.89% Payout Ratio
ABC arbitrage SA, together with its subsidiaries, develops arbitrage strategies for liquid assets worldwide. It develops liquidity, statistical, risk, and derivatives arbitrage strategies; and provides asset and portfolio management services. The company was incorporated in 1995 and is based in Paris, France.
Earnings Per Share
As for profitability, ABC ARBITRAGE has a trailing twelve months EPS of €0.6.
PE Ratio
ABC ARBITRAGE has a trailing twelve months price to earnings ratio of 10.66. Meaning, the purchaser of the share is investing €10.66 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.35%.
Volume
Today’s last reported volume for ABC ARBITRAGE is 5913 which is 72.17% below its average volume of 21253.
2. ORKLA (ORK.OL)
57.69% Payout Ratio
Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery retail trade, as well as the out-of-home, convenience store, and petrol station sectors. It also provides confectionery, biscuit, and snack products; and develops crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic garments; and professional cleaning products. Further, it operates Gymgrossisten and Bodystore e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, Abba, Kalles, Beauvais, Den Gamle Fabrik, Spilva, Vitana, MTR, and Eastern brands; confectionery and snacks under the KiMs, Nidar, Stratos, Göteborgs Kex, Sætre, OLW, Panda, Laima, Selga, Taffel, Adazu, and Kalev brands; health and sports nutrition under Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under Odense, Mors Hjemmebakte, KronJäst, Bakkedal and NATURLI' brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, ORKLA has a trailing twelve months EPS of kr4.37.
PE Ratio
ORKLA has a trailing twelve months price to earnings ratio of 15.98. Meaning, the purchaser of the share is investing kr15.98 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.77%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 21, 2022, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 4.32%.
Yearly Top and Bottom Value
ORKLA’s stock is valued at kr69.80 at 06:05 EST, way below its 52-week high of kr85.20 and above its 52-week low of kr67.06.
Moving Average
ORKLA’s worth is below its 50-day moving average of kr72.28 and under its 200-day moving average of kr75.72.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 12.1% and a negative 14.3%, respectively.
3. OENEO (SBT.PA)
47.62% Payout Ratio
Oeneo SA operates in the wine industry worldwide. The company manufactures and sale of cork closures. It also provides solutions in wine making and spirits. Oeneo SA is headquartered in Bordeaux, France. Oeneo SA is a subsidiary of Caspar SAS.
Earnings Per Share
As for profitability, OENEO has a trailing twelve months EPS of €0.63.
PE Ratio
OENEO has a trailing twelve months price to earnings ratio of 23.81. Meaning, the purchaser of the share is investing €23.81 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.71%.
Volume
Today’s last reported volume for OENEO is 2524 which is 45.7% below its average volume of 4649.
Yearly Top and Bottom Value
OENEO’s stock is valued at €15.00 at 06:05 EST, way under its 52-week high of €16.80 and way higher than its 52-week low of €13.35.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Oct 3, 2022, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 2%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.2%, now sitting on 340.62M for the twelve trailing months.
4. CEGEDIM (CGM.PA)
45.45% Payout Ratio
Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals worldwide. It operates in two divisions, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services division markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This division also provides solutions for hosting, HR and payroll management outsourcing, and electronic data exchange services. The Healthcare Professionals division offers management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SA.
Earnings Per Share
As for profitability, CEGEDIM has a trailing twelve months EPS of €0.78.
PE Ratio
CEGEDIM has a trailing twelve months price to earnings ratio of 21.45. Meaning, the purchaser of the share is investing €21.45 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.4%.
Moving Average
CEGEDIM’s value is under its 50-day moving average of €16.97 and under its 200-day moving average of €18.47.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 541.11M for the twelve trailing months.
Volume
Today’s last reported volume for CEGEDIM is 1397 which is 71.8% below its average volume of 4954.
Yearly Top and Bottom Value
CEGEDIM’s stock is valued at €16.82 at 06:05 EST, way under its 52-week high of €28.90 and way above its 52-week low of €13.56.
5. BOIRON (BOI.PA)
32.87% Payout Ratio
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €1.5.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 28.19. Meaning, the purchaser of the share is investing €28.19 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 35.2%, now sitting on 522.03M for the twelve trailing months.
Yearly Top and Bottom Value
BOIRON’s stock is valued at €42.20 at 06:05 EST, way under its 52-week high of €53.20 and way higher than its 52-week low of €37.30.
